Muhammad Z Khan, Sameh Nassar, Amanda Nguyen, Muhammad Usman Khan, Yasar Sattar, Waleed Alruwaili, Karthik Gonuguntla, Haitham Mazek, Zain Ul Abideen Asad, Siddharth Agarwal, Sameer Raina, Sudarshan Balla, Bao Nguyen, Dali Fan, Douglas Darden, Muhammad Bilal Munir
INTRODUCTION: Leadless pacemakers (LPM) have established themselves as the important therapeutic modality in management of selected patients with symptomatic bradycardia. To determine real-world utilization and in-hospital outcomes of LPM implantation since its approval by the Food and Drug Administration in 2016. METHODS: For this retrospective cohort study, data were extracted from the National Inpatient Sample database from the years 2016-2020. The outcomes analyzed in our study included implantation trends of LPM over study years, mortality, major complications (defined as pericardial effusion requiring intervention, any vascular complication, or acute kidney injury), length of stay, and cost of hospitalization...
May 2, 2024: Journal of Cardiovascular Electrophysiology